GNPX stock news · Genprex, Inc.

Stories about Genprex, Inc. (GNPX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for GNPX

Follow Genprex, Inc. (GNPX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 21, 2026, 7:12 AM ET · Market
Genprex, Inc. shares news about new research on the TUSC2 gene.
Neutral
Genprex reported research linking TUSC2 with brain aging in mice and human data. It did not test its cancer candidate, so the news leaves the company's outlook unchanged.
Oct 16, 2026, 5:18 PM ET · Market
12 health care stocks changed a lot in prices during Friday's after-hours trading.
Neutral
Genprex shares rose 7.1% in Friday's after-market session. The roundup gives no business news that changes its outlook.